Furthermore, in HF patients with T2DM the automatic vs. echo-guided CRTd optimization could significantly reduce the levels of inflammatory biomarkers (CRP, IL6, TNFa), and of BNP values via its favorable hemodynamic and clinical effects. This evidence concerns the gene IL6 and type 2 diabetes mellitus.